BT-13

BT-13 Suppliers list
Company Name: ATK CHEMICAL COMPANY LIMITED
Tel: +undefined-21-51877795
Email: ivan@atkchemical.com
Products Intro: Product Name:BT13
CAS:924537-98-4
Purity:98% Package:10MG;50MG;100MG,1G,5G,10G.100G
Company Name: TargetMol Chemicals Inc.
Tel: +1-781-999-5354 +1-00000000000
Email: marketing@targetmol.com
Products Intro: Product Name:BT-13
CAS:924537-98-4
Purity:98.00% Package:1 mg;10 mg;100 mg;200 mg;5 mg;50 mg Remarks:REAGENT;FOR LABORATORY USE ONLY
Company Name: Aladdin Scientific
Tel: +1-+1(833)-552-7181
Email: sales@aladdinsci.com
Products Intro: Product Name:BT-13
CAS:924537-98-4
Purity:99% Package:$180.9/5mg;$280.9/10mg;$850.9/50mg;Bulk package Remarks:99%
Company Name: ChemeGen(Shanghai) Biotechnology Co.,Ltd.  
Tel: 18818260767
Email: sales@chemegen.com
Products Intro: Product Name:BT-13
CAS:924537-98-4
Purity:98% Package:10 mg;50 mg;100 mg;500 mg;1 g;5 g;10 g
Company Name: Shanghai hongqu biomedical technology co. LTD  
Tel: 88888888888
Email: hongquchem@qq.com
Products Intro: Product Name:BT-13
CAS:924537-98-4
Purity:98% Package:100mg;1g;10g;100g;1kg
BT-13 Basic information
Product Name:BT-13
Synonyms:319H6;BT-13 (RET agonist BT13);BT 13 NEW;Benzenesulfonamide, N,N-diethyl-3-[4-[4-fluoro-2-(trifluoromethyl)benzoyl]-1-piperazinyl]-4-methoxy-;BT-13;RET,Inhibitor,BT-13,inhibit,BT13,BT 13;N,N-diethyl-3-[4-[4-fluoro-2-(trifluoromethyl)benzoyl]piperazin-1-yl]-4-methoxybenzenesulfonamide
CAS:924537-98-4
MF:C23H27F4N3O4S
MW:517.54
EINECS:
Product Categories:
Mol File:924537-98-4.mol
BT-13 Structure
BT-13 Chemical Properties
Boiling point 637.0±65.0 °C(Predicted)
density 1.326±0.06 g/cm3(Predicted)
storage temp. Store at -20°C
solubility DMSO: 25 mg/mL (48.31 mM)
pka0.42±0.20(Predicted)
form Solid
color White to off-white
Safety Information
MSDS Information
BT-13 Usage And Synthesis
Biological ActivityBT-13 is a potent, selective agonist of the glial cell-derived neurotrophic factor (GDNF) receptor RET (acts independently of GDNF ligands), promotes sensory neuron neurite outgrowth in vitro, and alleviates neuropathy in rats happened.
in vitro

BT-13 stimulates phosphorylation of RET, as well as RET-dependent intracellular signaling, but activated neither NGF receptor TrkA nor BDNF receptor TrkB nor intracellular signaling in the absence of RET.

< b>

in vivo

BT-13 (20 and 25mg/kg in rats induced by ligation of left L5 and L6 spinal nerves) has a slight antinociceptive/antihyperalgesic effect and protected DRG neurons in rats with surgery-induced neuropathy.

Animal Model: Rats induced by ligation of left L5 and L6 spinal nerves.
Dosage: 5-25 mg/kg, dissolved in sesame oil containing 5% DMSO.
Administration: Subcutaneous injections on post-surgical days 1, 3, 5, 8, 10, and 12.
Result: 20 and 25mg/kg decreased mechanical hypersensitivity and normalized expression of sensory neuron markers in dorsal root ganglia.
target

GDNF receptor RET.

BT-13 Preparation Products And Raw materials
Tag:BT-13(924537-98-4) Related Product Information